Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A genomic instability-derived risk index predicts clinical outcome and immunotherapy response for clear cell renal cell carcinoma.

Bioengineered - 1 Dec 2021

Wu Sha, Li Xiaoning

Abstract excerpt

This study aims to originate agenomic instability-derived risk index (GIRI) for prognostic analysis of clear cell renal cell carcinoma (ccRCC) and explore the mutation characteristics, immune characteristics, and immunotherapy response defined by GIRI. Differentially expressed genome instability-associated genes were obtained from the genomic unstable (GU) group and the genomic stable (GS) group. Rigorous...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Renal Cell
Share to Genomic Instability
Share to Immunotherapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Neoplasms

Share to Multivariate Analysis

Share to Proportional Hazards Models

Share to Survival Analysis

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 33955826
DOI: 10.1080/21655979.2021.1922330
PMCID: PMC8806326

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A genomic instability-derived risk index predicts clinical outcome and immunotherapy response for clear cell renal cell carcinoma.PMID 33955826Read ↗

Development of genomic instability-associated long non-coding RNA signature: a prognostic risk model of clear cell renal cell carcinomaSemantic proximity Read ↗

Identification of a novel anoikis-related gene signature and molecular subtype to predict prognosis and tumor microenvironment in clear cell renal cell carcinomaSemantic proximity Read ↗

A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinomaSemantic proximity Read ↗

Assessing the role of programmed cell death signatures and related gene TOP2A in progression and prognostic prediction of clear cell renal cell carcinomaSemantic proximity Read ↗

Construction of five disulfidptosis-related lncRNA signature for predicting prognosis and immune activity in kidney renal clear cell carcinomaSemantic proximity Read ↗

A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma PatientsSemantic proximity Read ↗

Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinomaSemantic proximity Read ↗

Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinomaSemantic proximity Read ↗

Multi-omics comprehensive analysis of renal clear cell carcinoma to distinguish subtypes with different molecular characterizations and therapeutic strategiesSemantic proximity Read ↗

Construction of a five-disulfidptosis-related-lncRNA signature for predicting prognosis and immune activity in kidney renal clear cell carcinomaSemantic proximity Read ↗

Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysisSemantic proximity Read ↗

Characterization of a G2M checkpoint-related gene model and subtypes associated with immunotherapy response for clear cell renal cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.